Biological and Medical Sciences Research Infrastructures (BMS RI) Strategy Board publishes joint statement advocating for coherent roadmapping process

Published 12 December 2018

In September 2018, ESFRI published the 2018 Roadmap, identifying pan-European Research Infrastructure (RI) projects to complement the existing projects and landmarks. Each was selected for “their strategic potential and impact for strengthening European research,” with a view to providing trans-national access to unique scientific infrastructure and resources that are not uniformly accessible to the community.
ESFRI RIs are grouped in six thematic domains, including Health and Food (H&F), under which the RIs active in biological sciences, biological resources and medical sciences are listed. As of 2018, the H&F group of RIs is comprised of 10 Landmarks and 6 Projects, 13 of which are represented in the BMS RI Strategy Board, chaired by Anton Ussi, EATRIS Operations & Finance Director since October 2018.

As the ESFRI roadmap matures and grows, the BMS RI Strategy Board believes that a critical success factor is an optimal coordination process that facilitates the input of all relevant actors in the community. This will result in a continued healthy, cost-effective and unfragmented RI eco-system covering the most important areas of biomedical scientific research.

Read the full statement